AV
Atlas Venture Opportunity Fund I, LP
Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by Atlas Venture Opportunity Fund I, LP. Insider active across 3 companies, notably Dyne Therapeutics, Inc.. In total, 19 filings have been logged. History available since 17 June 2026. The latest transaction was filed on 4 September 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Atlas Venture Opportunity Fund I, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
912 shares@ US$79.37Common StockSEC144:0001628280-26-060746
2,810 shares@ US$80.05Common StockSEC144:0001628280-26-060504
322,465 shares@ US$25.960.17% mcap48.8% of flowCommonSEC144:0001628280-26-057191
63,643 shares@ US$26.170.033% mcap19.0% of flowCommonSEC144:0001628280-26-056842
60,858 shares@ US$22.840.035% mcap37.6% of flowCommonSEC144:0001628280-26-047534
100,019 shares@ US$23.070.059% mcap62.4% of flowCommonSEC144:0001628280-26-047358
40,702 shares@ US$20.940.017% mcap14.5% of flowCommonSEC144:0001628280-26-046093
10,473 shares@ US$108.120.012% mcap14.4% of flowCommon StockSEC144:0001628280-26-046098
64,411 shares@ US$20.610.027% mcap22.7% of flowCommonSEC144:0001628280-26-045818
57,451 shares@ US$116.460.069% mcap85.6% of flowCommon StockSEC144:0001628280-26-045807
67,329 shares@ US$99.870.069% mcap31.1% of flowCommon StockSEC144:0001628280-26-045610
5,019 shares@ US$20.330.0021% mcap1.5% of flowCommonSEC144:0001628280-26-045612
16,542 shares@ US$98.250.017% mcap7.5% of flowCommon StockSEC144:0001628280-26-045289
19,973 shares@ US$20.260.0083% mcap5.8% of flowCommonSEC144:0001628280-26-045294
173 shares@ US$99.450.0002% mcap0.1% of flowCommon StockSEC144:0001628280-26-044985
30,774 shares@ US$20.870.013% mcap9.2% of flowCommonSEC144:0001628280-26-044988
34,152 shares@ US$90.430.031% mcap14.2% of flowCommon StockSEC144:0001628280-26-044732
14,128 shares@ US$89.900.013% mcap5.8% of flowCommon StockSEC144:0001628280-26-044426
12,902 shares@ US$87.440.011% mcap5.1% of flowCommon StockSEC144:0001628280-26-044012
About Atlas Venture Opportunity Fund I, LP
Atlas Venture Opportunity Fund I, LP is a shareholder of Kymera Therapeutics, Inc. and Dyne Therapeutics, Inc. The declarant has 15 filings in total, and among the recent filings observed between 2026-06-17 and 2026-07-07, all are sales for a total of EUR 25193498, with the most frequent transaction nature being a notice of proposed sale (Form 144).